200 related articles for article (PubMed ID: 10362511)
1. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression.
Rovin BH; Lu L; Saxena R
Biochem Biophys Res Commun; 1999 Jun; 259(2):344-8. PubMed ID: 10362511
[TBL] [Abstract][Full Text] [Related]
2. Identification of new regulatory sequences far upstream of the mouse monocyte chemoattractant protein-1 gene.
Wagner K; Dendorfer U; Chilla S; Schlöndorff D; Luckow B
Genomics; 2001 Dec; 78(3):113-23. PubMed ID: 11735217
[TBL] [Abstract][Full Text] [Related]
3. The combination of polymorphisms within MCP-1 and IL-1beta associated with ulcerative colitis.
Li KS; Wang BY; Liu SY; Yao SP; Guo L; Mao DW
Int J Immunogenet; 2009 Jun; 36(3):135-9. PubMed ID: 19392835
[TBL] [Abstract][Full Text] [Related]
4. Differential induction of JE/MCP-1 in subclones from a murine macrophage cell line, RAW 264.7: role of kappaB-3 binding protein.
Ueno M; Sonoda Y; Funakoshi M; Mukaida N; Nose K; Kasahara T
Cytokine; 2000 Mar; 12(3):207-19. PubMed ID: 10704247
[TBL] [Abstract][Full Text] [Related]
5. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter.
Amini Nekoo A; Iles D
Thromb Res; 2008; 121(6):813-9. PubMed ID: 17931693
[TBL] [Abstract][Full Text] [Related]
6. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene.
Bayerer B; Stamer U; Hoeft A; Stüber F
Eur J Pain; 2007 May; 11(4):421-7. PubMed ID: 16843022
[TBL] [Abstract][Full Text] [Related]
7. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis.
Tucci M; Barnes EV; Sobel ES; Croker BP; Segal MS; Reeves WH; Richards HB
Arthritis Rheum; 2004 Jun; 50(6):1842-9. PubMed ID: 15188361
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F; Marciano R; Pistorio A; Catarsi P; Canini S; Karsenty G; Ravazzolo R
Physiol Genomics; 2004 Dec; 20(1):87-96. PubMed ID: 15479859
[TBL] [Abstract][Full Text] [Related]
9. No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Neurosci Lett; 2004 Apr; 360(1-2):25-8. PubMed ID: 15082170
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activity of the tandem repeat polymorphism in the 5'-flanking region of the human CYP2E1 gene.
Nomura F; Itoga S; Uchimoto T; Tomonaga T; Nezu M; Shimada H; Ochiai T
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):42S-46S. PubMed ID: 12960506
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms and functions of the aldose reductase gene 5' regulatory region in Chinese patients with type 2 diabetes mellitus.
Li Q; Xie P; Huang J; Gu Y; Zeng W; Song H
Chin Med J (Engl); 2002 Feb; 115(2):209-13. PubMed ID: 11940333
[TBL] [Abstract][Full Text] [Related]
12. Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD.
Riazanskaia N; Lukiw WJ; Grigorenko A; Korovaitseva G; Dvoryanchikov G; Moliaka Y; Nicolaou M; Farrer L; Bazan NG; Rogaev E
Mol Psychiatry; 2002; 7(8):891-8. PubMed ID: 12232783
[TBL] [Abstract][Full Text] [Related]
13. A three-base-deletion polymorphism in the upstream non-coding region of human interleukin 7 (IL-7) gene could enhance levels of IL-7 expression.
Song H; Nakayama EE; Likanonsakul S; Wasi C; Iwamoto A; Shioda T
Int J Immunogenet; 2007 Apr; 34(2):107-13. PubMed ID: 17373935
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of human ornithine decarboxylase alleles.
Guo Y; Harris RB; Rosson D; Boorman D; O'Brien TG
Cancer Res; 2000 Nov; 60(22):6314-7. PubMed ID: 11103791
[TBL] [Abstract][Full Text] [Related]
15. EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts.
Largo R; Díez-Ortego I; Sanchez-Pernaute O; López-Armada MJ; Alvarez-Soria MA; Egido J; Herrero-Beaumont G
Ann Rheum Dis; 2004 Oct; 63(10):1197-204. PubMed ID: 15361371
[TBL] [Abstract][Full Text] [Related]
16. Differential roles of C/EBP beta regulatory domains in specifying MCP-1 and IL-6 transcription.
Spooner CJ; Guo X; Johnson PF; Schwartz RC
Mol Immunol; 2007 Feb; 44(6):1384-92. PubMed ID: 16784777
[TBL] [Abstract][Full Text] [Related]
17. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha.
Dominici R; Cattaneo M; Malferrari G; Archi D; Mariani C; Grimaldi LM; Biunno I
Immunogenetics; 2002 May; 54(2):82-6. PubMed ID: 12037600
[TBL] [Abstract][Full Text] [Related]
18. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis.
Wang L; Yang L; Gao L; Gao TW; Li W; Liu YF
Int J Immunogenet; 2008 Feb; 35(1):45-9. PubMed ID: 18093183
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus.
Liao CH; Yao TC; Chung HT; See LC; Kuo ML; Huang JL
J Rheumatol; 2004 Oct; 31(10):2062-7. PubMed ID: 15468376
[TBL] [Abstract][Full Text] [Related]
20. Association of CT dinucleotide repeat polymorphism in the 5'-flanking region of the guanylyl cyclase (GC)-A gene with essential hypertension in the Japanese.
Usami S; Kishimoto I; Saito Y; Harada M; Kuwahara K; Nakagawa Y; Nakanishi M; Yasuno S; Kangawa K; Nakao K
Hypertens Res; 2008 Jan; 31(1):89-96. PubMed ID: 18360023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
